Squarepoint’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-159
| Closed | -$6K | – | 2652 |
|
|
2022
Q2 | $6K | Sell |
159
-9
| -5% | -$340 | ﹤0.01% | 2054 |
|
|
2022
Q1 | $7K | Sell |
168
-27
| -14% | -$1.13K | ﹤0.01% | 2159 |
|
|
2021
Q4 | $8K | Buy |
195
+6
| +3% | +$246 | ﹤0.01% | 2493 |
|
|
2021
Q3 | $13K | Sell |
189
-1,442
| -88% | -$99.2K | ﹤0.01% | 2168 |
|
|
2021
Q2 | $126K | Buy |
1,631
+1,447
| +786% | +$112K | ﹤0.01% | 2374 |
|
|
2021
Q1 | $12K | Buy |
+184
| New | +$12K | ﹤0.01% | 2494 |
|
|
2020
Q4 | – | Sell |
-315
| Closed | -$17K | – | 2965 |
|
|
2020
Q3 | $17K | Buy |
315
+86
| +38% | +$4.64K | ﹤0.01% | 2262 |
|
|
2020
Q2 | $9K | Buy |
+229
| New | +$9K | ﹤0.01% | 2092 |
|
|
2018
Q4 | – | Sell |
-144
| Closed | -$35K | – | 2295 |
|
|
2018
Q3 | $35K | Buy |
+144
| New | +$35K | ﹤0.01% | 1923 |
|